The passage of the 2018 Farm Bill would be the "first step" toward Canopy Growth activity in the United States, the company's chief executive told CNBC on Wednesday.
Mallinckrodt's shares fell 4.4 percent to $20.02 in premarket trading on Wednesday. Mallinckrodt is one of the nation's largest manufacturers of oxycodone- the most commonly abused prescription painkiller after hydrocodone in 2016.. The panel members, during the Nov. 14 meeting, also raised concerns of Mallinckrodt's treatment creating the same problem...
Certain parts of the company's application need further evaluation, Mallinckrodt said, citing the FDA. The treatment is a reformulated version of Mallinckrodt's commonly abused painkiller Roxicodone, intended to make the drug less desirable and more difficult to be abused by snorting or injecting. The decision comes after an advisory panel to the FDA voted...
Constellation Brands's healthy revenue growth in the U.S. beer market, paired with strong profitability and a new investment in cannabis makes the stock one of Cowen's top stock picks heading into 2019.
Wall Street's top marijuana analyst likes Marlboro maker Altria's $1.8 billion investment in Canadian pot company Cronos Group, telling clients the move represents a "unique entry into cannabis."
Mallinckrodt's shares fell 7.5 percent to $21.41 on Thursday morning. The generics business, which generated revenue of $839.5 million in fiscal 2017, largely makes opioid drugs and has come under pressure as more doctors in the United States shy away from prescribing the addictive medicines that had claimed nearly 50,000 lives last year.
Amgen, updating the first trial of its bispecific antibody for multiple myeloma, said seven out of 10 patients given the second-highest dose of AMG420 responded to the drug.
The agreement between President Donald Trump and President Xi Jinping reached at the G-20 summit to prevent the flow of illegal fentanyl from China to the United States has been greeted with cautious optimism by lawmakers and experts.
Express Scripts Chief Medical Officer Steve Miller tells Bertha Coombs he thinks Washington is moving in the right direction on bringing down drug prices. "This is a great moment where we now have allies in the White House and allies at HHS," he said, while more drug makers are also willing to work with his firm on affordability.
Teva Pharmaceutical is recalling certain combinations of blood pressure drug valsartan in the U.S. following the detection of a probable cancer-causing impurity.
Prosecutors are seeking to sanction defense lawyers for accused Mexican drug lord Joaquin "El Chapo" Guzman in connection with alleged prohibited use of a cellphone by his wife, Emma Coronel Aispuro.
Alex Azar, Secretary of Health and Human Services, joins 'Squawk Box' to discuss lowering drug prices and how the government is planning on modernizing Medicare.
Scott Gottlieb, FDA Commissioner, joins 'Squawk Box' to discuss medical device safety, flu vaccinations and rising drug prices.
Scott Gottlieb, FDA Commissioner, joins 'Squawk Box' to discuss the romaine lettuce recall, medical device safety, flu vaccinations and rising drug prices.
The U.S. Court of Appeals for the Federal Circuit lifted a preliminary injunction that blocked Dr. Suboxone Film generates 80 percent of UK- based Indiviors revenue and helps drug users beat their addiction to opioids and is dissolved under the tongue. Indivior's contingency plans also focus on optimizing the launch of Sublocade, a once-a-month injectable...
Florida is suing the nation's two largest drugstore chains, Walgreens and CVS, alleging they added to the state and national opioid crisis by overselling painkillers and not taking precautions to stop illegal sales.
Cannabis companies Tilray, Canopy Growth and Aurora Cannabis all took big stock hits after earnings losses outweighed revenue growth. While demand is high, marijuana growers are struggling to increase supply, and long-term investors should be wary.
Marijuana producer Tilray reported quarterly earnings that beat analysts' expectations on Tuesday, though total revenues fell just shy of estimates.
Aurora Cannabis reported on Monday that revenue jumped 260 percent over the last 12 months, with kilograms produced climbing to 4,996 from 1,010 over the past year.
The FDA also will introduce stricter age-verification requirements for online sales of e-cigarettes. There has been mounting pressure for action after preliminary federal data showed teenage use had surged by more than 75 percent since last year, and the FDA has described it as an "epidemic". The FDA gave Juul and four big tobacco companies 60 days to submit...